Please assess the completion status of the following clinical trial:

Trial Title: Relationship Between Evolution of Resting Energy Expenditure and Tumoral Response to Chemotherapy in Patients Suffering From Pancreas Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Pancreatic metastatic cancer~* Patient older than 18 years~* Initiation of a first line of chemotherapy by Folfirinox, or Gemcitabine or in combination with Nab-Paclitaxel.~* At least one measurable target lesion~* Patient signed consent for Energie-Pancreas study participation~Exclusion Criteria:~* Other concomitant cancer~* Major general status alteration ( Performance status = 3 or 4 at inclusion)~* Concomitant diseases explaining an altered general status or having an impact on energetic expenditure (i.e.chronic or severe infection, severe cardiac insufficiency, severe respiratory insufficiency, chronic inflammatory disease, recent surgery (\< 1 month), ongoing Healing, hyperthyroidism.~* Smoker~* Patient deprived of his liberty, under guardianship, curator.~* Pregnant patient or breastfeeding~* Claustrophobic patient

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- energetic expenditure measure (Type: OTHER): To a standard treatment by chemotherapy, energetic expenditure will be measured 5 times during the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).